Join to View Full Profile
1707 N Mills AveOrlando, FL 32803
Phone+1 407-647-3960
Fax+1 407-413-5775
Dr. Hinestrosa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MedStar Health Georgetown University/Washington Hospital CenterFellowship, Infectious Disease, 2007 - 2009
Geisinger Health System (Danville)Residency, Internal Medicine, 2004 - 2007
Universidad CESClass of 1997
Certifications & Licensure
FL State Medical License 2009 - 2027
DC State Medical License 2007 - 2010
PA State Medical License 2004 - 2007
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Practice Solution EMR, GE Healthcare, 2014
Clinical Trials
- Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects Start of enrollment: 2017 Apr 20
Publications & Presentations
PubMed
- Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, ...Jürgen K Rockstroh, Roger Paredes, Pedro Cahn, Jean-Michel Molina, Simiso M Sokhela
Clinical Infectious Diseases. 2025-03-13 - Change in weight and BMI associated with switching to bictegravir/emtricitabine/tenofovir alafenamide versus a dolutegravir-based regimen among virologically suppresse...Charlotte-Paige Rolle, Jeffrey Garrett, Jamie Castano, Vu Nguyen, Kiran Patel
Medicine. 2025-03-07 - Efficacy, Safety, and Tolerability of Switching From Bictegravir/Emtricitabine/Tenofovir Alafenamide to Dolutegravir/Lamivudine Among Adults With Virologically Suppres...Charlotte-Paige Rolle, Jamie Castano, Vu Nguyen, Federico Hinestrosa, Edwin DeJesus
Open Forum Infectious Diseases. 2024-10-01
Press Mentions
Treatment-Related Early Discontinuations and Adverse Events Among Newly Diagnosed People Living with HIV Initiating Integrase Inhibitors in a Real-World SettingFebruary 1st, 2023- Finest Doctors of 2020: A Unique CallingDecember 4th, 2020
- Finest Doctors of 2020: The Mysteries of COVID-19December 3rd, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
